During the past decade, Hopital Saint Michel conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Saint Michel" are "Breast Cancer" (2 trials), "Diabetes Mellitus Type 2" (1 trials), "Heart Failure, Congestive" (1 trials), "Hereditary Breast/Ovarian Cancer (brca1, brca2)" (1 trials) and "Kidney Cancer" (1 trials). Many other conditions were trialed in "Hopital Saint Michel" in a lesser frequency.

Most popular intervention types in "Hopital Saint Michel" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (2 trials), "Docetaxel" (1 trials), "Inhaled Insulin (Exubera)" (1 trials), "Placebo" (1 trials) and "Standard of Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Saint Michel" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hopital Saint Michel". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hopital Saint Michel, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Saint Michel, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".